older glp 1 drugs GLP-1 Could Double Risk of Severe Eye Disease in Adults With Diabetes Seniors abandon GLP-1 weight-loss drugs
Description
Given all these unknowns, it may be best for Congress to pump the brakes on expanding GLP-1s in Medicare before we have a better understanding of their full value and a way to pay for it.

Moreover, there are differences in how these products are made, and the ingredients may come from undisclosed sources

Abstract from the 83rd American Diabetes Association meeting

GLP-1 Targeted Peptide Weight Loss Drugs Market Share, by Drug, 20242034 Figure 2: U.S
